Official: US to spend $3B for antiviral pills for COVID-19
WASHINGTON (AP) — The United States is devoting more than $3 billion to advance development of antiviral pills for COVID-19, according to an official briefed on the matter.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
